Array BioPharma (NASDAQ: ARRY), G1 Therapeutics (NASDAQ: GTHX), and CEL-SCI (NYSEMKT: CVM) skyrocketed last week by at last 37%. Here's what lit a fire beneath these three biotech stocks and whether or not they're smart picks for investors to buy now.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,